List of Tables
Table 1. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cholinesterase Inhibitors
Table 3. Key Players of Memantine
Table 4. Key Players of Combination Drugs
Table 5. Global Dementia and Alzheimer’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2020-2025)
Table 9. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region (2026-2031)
Table 11. Dementia and Alzheimer’s Disease Treatment Market Trends
Table 12. Dementia and Alzheimer’s Disease Treatment Market Drivers
Table 13. Dementia and Alzheimer’s Disease Treatment Market Challenges
Table 14. Dementia and Alzheimer’s Disease Treatment Market Restraints
Table 15. Global Dementia and Alzheimer’s Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players (2020-2025)
Table 17. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2024)
Table 18. Ranking of Global Top Dementia and Alzheimer’s Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Headquarters and Area Served
Table 21. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Product and Application
Table 22. Global Key Players of Dementia and Alzheimer’s Disease Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dementia and Alzheimer’s Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Dementia and Alzheimer’s Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Dementia and Alzheimer’s Disease Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Dementia and Alzheimer’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Dementia and Alzheimer’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Dementia and Alzheimer’s Disease Treatment Product
Table 50. Novartis Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Pfizer, Inc. Company Details
Table 53. Pfizer, Inc. Business Overview
Table 54. Pfizer, Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 55. Pfizer, Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 56. Pfizer, Inc. Recent Development
Table 57. AbbVie Inc. Company Details
Table 58. AbbVie Inc. Business Overview
Table 59. AbbVie Inc. Dementia and Alzheimer’s Disease Treatment Product
Table 60. AbbVie Inc. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 61. AbbVie Inc. Recent Development
Table 62. Allergan plc Company Details
Table 63. Allergan plc Business Overview
Table 64. Allergan plc Dementia and Alzheimer’s Disease Treatment Product
Table 65. Allergan plc Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 66. Allergan plc Recent Development
Table 67. Eli Lilly and Company Company Details
Table 68. Eli Lilly and Company Business Overview
Table 69. Eli Lilly and Company Dementia and Alzheimer’s Disease Treatment Product
Table 70. Eli Lilly and Company Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 71. Eli Lilly and Company Recent Development
Table 72. F. Hoffmann-La Roche Ltd. Company Details
Table 73. F. Hoffmann-La Roche Ltd. Business Overview
Table 74. F. Hoffmann-La Roche Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 75. F. Hoffmann-La Roche Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd. Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Dementia and Alzheimer’s Disease Treatment Product
Table 80. AstraZeneca Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Biogen Company Details
Table 83. Biogen Business Overview
Table 84. Biogen Dementia and Alzheimer’s Disease Treatment Product
Table 85. Biogen Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 86. Biogen Recent Development
Table 87. Eisai Co., Ltd. Company Details
Table 88. Eisai Co., Ltd. Business Overview
Table 89. Eisai Co., Ltd. Dementia and Alzheimer’s Disease Treatment Product
Table 90. Eisai Co., Ltd. Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 91. Eisai Co., Ltd. Recent Development
Table 92. INmuneBIO Company Details
Table 93. INmuneBIO Business Overview
Table 94. INmuneBIO Dementia and Alzheimer’s Disease Treatment Product
Table 95. INmuneBIO Revenue in Dementia and Alzheimer’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 96. INmuneBIO Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Dementia and Alzheimer’s Disease Treatment Picture
Figure 2. Global Dementia and Alzheimer’s Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Dementia and Alzheimer’s Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Cholinesterase Inhibitors Features
Figure 5. Memantine Features
Figure 6. Combination Drugs Features
Figure 7. Global Dementia and Alzheimer’s Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Dementia and Alzheimer’s Disease Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Dementia and Alzheimer’s Disease Treatment Report Years Considered
Figure 12. Global Dementia and Alzheimer’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Dementia and Alzheimer’s Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Dementia and Alzheimer’s Disease Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Dementia and Alzheimer’s Disease Treatment Market Share by Players in 2024
Figure 16. Global Top Dementia and Alzheimer’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia and Alzheimer’s Disease Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Dementia and Alzheimer’s Disease Treatment Revenue in 2024
Figure 18. North America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2020-2031)
Figure 20. United States Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Dementia and Alzheimer’s Disease Treatment Market Share by Country (2020-2031)
Figure 24. Germany Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Dementia and Alzheimer’s Disease Treatment Market Share by Region (2020-2031)
Figure 32. China Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Dementia and Alzheimer’s Disease Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Dementia and Alzheimer’s Disease Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Dementia and Alzheimer’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 48. Pfizer, Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 49. AbbVie Inc. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 50. Allergan plc Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 51. Eli Lilly and Company Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 53. AstraZeneca Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 54. Biogen Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 55. Eisai Co., Ltd. Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 56. INmuneBIO Revenue Growth Rate in Dementia and Alzheimer’s Disease Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
